
Sign up to save your podcasts
Or


This week OTM shares the second episode of the three-part series, Hard, produced by our WNYC colleagues at Death, Sex & Money. In this installment, the team dives into the scientific advancements that led to Viagra's FDA approval in 1998. From an unforgettable conference presentation...to an overnight drug study, where an unexpected side effect kept popping up. Also the intentionality around the early marketing of Viagra—when former Senate Majority Leader Bob Dole encouraged men to summon the bravery to talk to their doctors—and how that message has shifted over the years.
You can hear more from Death, Sex & Money here.
On the Media is supported by listeners like you. Support OTM by donating today (https://pledge.wnyc.org/support/otm). Follow our show on Instagram, Bluesky, TikTok and Facebook @onthemedia, and share your thoughts with us by emailing [email protected].
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By WNYC Studios4.6
88578,857 ratings
This week OTM shares the second episode of the three-part series, Hard, produced by our WNYC colleagues at Death, Sex & Money. In this installment, the team dives into the scientific advancements that led to Viagra's FDA approval in 1998. From an unforgettable conference presentation...to an overnight drug study, where an unexpected side effect kept popping up. Also the intentionality around the early marketing of Viagra—when former Senate Majority Leader Bob Dole encouraged men to summon the bravery to talk to their doctors—and how that message has shifted over the years.
You can hear more from Death, Sex & Money here.
On the Media is supported by listeners like you. Support OTM by donating today (https://pledge.wnyc.org/support/otm). Follow our show on Instagram, Bluesky, TikTok and Facebook @onthemedia, and share your thoughts with us by emailing [email protected].
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

90,994 Listeners

43,898 Listeners

38,062 Listeners

6,826 Listeners

26,197 Listeners

4,038 Listeners

3,998 Listeners

8,454 Listeners

3,541 Listeners

4,681 Listeners

111,948 Listeners

2,374 Listeners

16,399 Listeners

667 Listeners

15,950 Listeners

15 Listeners